| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Amyris Inc (NASDAQ: AMRS)
AMRS Technical Analysis
5
| As on 9th Jun 2023 AMRS SHARE Price closed @ 1.26 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.31 & Strong Sell for SHORT-TERM with Stoploss of 4.68 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AMRSSHARE Price
| Open | 1.22 | Change | Price | % |
| High | 1.27 | 1 Day | 0.05 | 4.13 |
| Low | 1.13 | 1 Week | 0.42 | 50.00 |
| Close | 1.26 | 1 Month | 0.48 | 61.54 |
| Volume | 4374100 | 1 Year | -4.44 | -77.89 |
| 52 Week High 5.86 | 52 Week Low 0.58 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| AMRS Daily Charts |
AMRS Intraday Charts |
Whats New @ Bazaartrend |
AMRS Free Analysis |
|
|
AMRS Important Levels Intraday
| RESISTANCE | 1.53 |
| RESISTANCE | 1.44 |
| RESISTANCE | 1.39 |
| RESISTANCE | 1.34 |
| SUPPORT | 1.18 |
| SUPPORT | 1.13 |
| SUPPORT | 1.08 |
| SUPPORT | 0.99 |
AMRS Forecast April 2024
| 4th UP Forecast | 4.98 |
| 3rd UP Forecast | 3.79 |
| 2nd UP Forecast | 3.05 |
| 1st UP Forecast | 2.31 |
| 1st DOWN Forecast | 0.21 |
| 2nd DOWN Forecast | -0.53 |
| 3rd DOWN Forecast | -1.27 |
| 4th DOWN Forecast | -2.46 |
AMRS Weekly Forecast
| 4th UP Forecast | 3.84 |
| 3rd UP Forecast | 3.01 |
| 2nd UP Forecast | 2.50 |
| 1st UP Forecast | 1.99 |
| 1st DOWN Forecast | 0.53 |
| 2nd DOWN Forecast | 0.02 |
| 3rd DOWN Forecast | -0.49 |
| 4th DOWN Forecast | -1.32 |
AMRS Forecast2024
| 4th UP Forecast | 12.48 |
| 3rd UP Forecast | 8.88 |
| 2nd UP Forecast | 6.66 |
| 1st UP Forecast | 4.43 |
| 1st DOWN Forecast | -1.91 |
| 2nd DOWN Forecast | -4.14 |
| 3rd DOWN Forecast | -6.36 |
| 4th DOWN Forecast | -9.96 |
Amyris Inc ( NASDAQ USA Symbol : AMRS )
Sector : Basic Materials And Other Stocks in Same Sector
Sector : Basic Materials And Other Stocks in Same Sector
AMRS Business Profile
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty markets through its consumer brands and as a supplier of sustainable and natural ingredients in Europe, the United States, Asia, Brazil, and internationally. It manufactures and sells products for the health and wellness, clean beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. Amyris, Inc. has a collaboration agreement with the Infectious Disease Research Institute to advance a novel ribonucleic acid vaccine platform, including accelerating the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California. Address: 5885 Hollis Street, EmeryVille, CA, United States, 94608
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service